Providentia Technologies Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $150K

  • Investors
  • 4

Providentia Technologies General Information

Description

Developer of biotechnology tools designed to predict early-stage toxicity in drug development. The company utilizes synthetic cell membrane screening technology and machine learning to identify and modify drug properties that cause toxicity, enabling pharmaceutical companies to reduce costs and improve drug safety.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11 East Loop Road
  • Tata Innovation Center, Room 381
  • New York, NY 10044
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Corporate Office
  • 11 East Loop Road
  • Tata Innovation Center, Room 381
  • New York, NY 10044
  • United States

Providentia Technologies Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Providentia Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 15-Apr-2026 $150K Completed Startup
4. Accelerator/Incubator 04-Feb-2025 Completed Startup
3. Accelerator/Incubator 30-Nov-2023 Completed Startup
2. Corporate Completed Startup
1. University Spin-Out 01-Jan-2022 Completed Startup
To view Providentia Technologies’s complete valuation and funding history, request access »

Providentia Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Providentia Technologies Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Jersey Economic Development Authority Government
Westchester County Biosciences Accelerator Accelerator/Incubator
Merck Digital Sciences Studio Accelerator/Incubator
Cornell University University
To view Providentia Technologies’s complete investors history, request access »

Providentia Technologies FAQs

  • When was Providentia Technologies founded?

    Providentia Technologies was founded in 2022.

  • Where is Providentia Technologies headquartered?

    Providentia Technologies is headquartered in New York, NY.

  • What is the size of Providentia Technologies?

    Providentia Technologies has 2 total employees.

  • What industry is Providentia Technologies in?

    Providentia Technologies’s primary industry is Discovery Tools (Healthcare).

  • Is Providentia Technologies a private or public company?

    Providentia Technologies is a Private company.

  • What is Providentia Technologies’s current revenue?

    The current revenue for Providentia Technologies is .

  • How much funding has Providentia Technologies raised over time?

    Providentia Technologies has raised $300K.

  • Who are Providentia Technologies’s investors?

    New Jersey Economic Development Authority, Westchester County Biosciences Accelerator, Merck Digital Sciences Studio, and Cornell University have invested in Providentia Technologies.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process